Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | January 30, 2007 | February 02, 2007 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date January 30, 2007 · Filed February 02, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 108,521 |
Ending reported balance
After 2007-01-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2007-01-30 · Exercise / conversion · Acquired 16,623 · Balance 122,628 Row 2 · 2007-01-30 · Tax withholding · Disposed 14,107 · Balance 108,521 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.03 · Expires 2014-02-19 | Direct | 25,938 |
Reported balance
After 2007-01-30 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2007-01-30 · Exercise / conversion · Disposed 16,623 · Balance 25,938 F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.66 · Expires 2014-02-19 | Direct | 14,107 |
Reported balance
After 2007-01-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2007-01-30 · Grant · Acquired 14,107 · Balance 14,107 F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 9,621 |
Reported balance
Holding disclosure · report date 2007-01-30 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 9,621 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 30, 2007. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 30, 2007.
F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2007 Filed Feb 2, 2007 00:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 14,107 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-07-006575 · a4.xml · derivative · entry 5 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,107 Underlying: Common shares · 14,107 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 16,623 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-006575 · a4.xml · derivative · entry 4 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,938 Underlying: Common shares · 16,623 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 14,107 | $52.66 | $742,874.62 |
DisclosureSEC source: 0001104659-07-006575 · a4.xml · nonDerivative · entry 2 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,521 Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 16,623 | $41.03 | $682,069.95 |
DisclosureSEC source: 0001104659-07-006575 · a4.xml · nonDerivative · entry 1 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 16,165 | $0.00 Strike: $48.66 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 14 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,165 Underlying: common shares · 16,165 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,054 | $0.00 Strike: $48.66 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 13 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,054 Underlying: common shares · 2,054 shares Expires 2008-02-12 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 20,005 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 12 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: common shares · 20,005 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,653 | $0.00 Strike: $40.74 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 11 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,653 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,831 | $0.00 Strike: $43.99 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 10 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,831 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 5,553 | $0.00 Strike: $39.92 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 9 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 5,553 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 8 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 28,081 | $48.66 | $1,366,421.46 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 6 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,005 Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 20,005 | $33.23 | $664,794.16 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 5 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,653 | $40.74 | $108,083.22 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 4 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,831 | $43.99 | $124,528.33 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 3 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 5,553 | $39.92 | $221,691.31 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 2 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 1 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2006 Filed Feb 22, 2006 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 234 | $43.86 | $10,263.24 |
DisclosureSEC source: 0001104659-06-011232 · a4.xml · nonDerivative · entry 3 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,169 Read SEC document |
| February 18, 2006 Filed Feb 22, 2006 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 740 | $44.15 | $32,671.00 |
DisclosureSEC source: 0001104659-06-011232 · a4.xml · nonDerivative · entry 1 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,903 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011232 · a4.xml · derivative · entry 5 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common Shares · 83,000 shares Expires 2016-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/17/2007, 27,667 on 02/17/2008 and 27,666 on 02/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011232 · a4.xml · nonDerivative · entry 2 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,403 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 20:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,998 | $0.00 Strike: $39.92 | $0.00 |
DisclosureSEC source: 0001104659-06-005327 · a4.xml · derivative · entry 4 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,998 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 20:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,998 | $42.30 | $169,115.40 |
DisclosureSEC source: 0001104659-06-005327 · a4.xml · nonDerivative · entry 2 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,643 Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 20:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,998 | $39.92 | $159,611.35 |
DisclosureSEC source: 0001104659-06-005327 · a4.xml · nonDerivative · entry 1 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2006 Filed Jan 4, 2006 21:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,000 | $39.58 | $118,740.00 |
DisclosureSEC source: 0001104659-06-000365 · a4.xml · nonDerivative · entry 1 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,643 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.